This site is intended for healthcare professionals only
LoginRegister
Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone LymphomaBristol Myers Squibb gets European Commission nod for Breyanzi for follicular lymphoma
CDSCO Panel Seeks Revised Phase IV Study for Zydus Empagliflozin, Metformin FDCCDSCO Panel suggests revising phase III CT protocol of Zydus Healthcare's Empagliflozin plus...
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIAConduct BE study or present safety data: CDSCO Panel tells IQVIA on anti-cancer Drug Daratumumab...
Shilpa Medicare Enters US Transdermal Market, Files First ANDA for Rotigotine PatchUSFDA concludes inspection at Shilpa Medicare Raichur unit
Alkem Labs Slapped Rs 2.34 Cr GST Demand in GoaUSFDA inspection: Alkem Labs concludes inspection at Taloja Center
JB Chemicals Panoli facility concludes USFDA inspection no observationsJB Chemicals and Pharma Panoli facility concludes USFDA inspection no observations
Granules India packaging facility in US successfully completes USFDA inspectionUSFDA concludes inspection at Zydus Lifesciences Ankleshwar facility
168 drug samples failed quality checks in HP in past 3 years, says Health Minister1471 drugs samples manufactured in HP failed quality tests in past two years: Minister
Windlas Biotech Gets SEC Nod to Manufacture Dapagliflozin-Pioglitazone FDCModify Phase III CT protocol: CDSCO panel Tells Windlas Biotech on FDC Tamsulosin plus Mirabegron
Synokem Pharmaceutical Gets CDSCO Panel Nod To Study Anti-rheumatoid drug IguratimodSynokem Pharmaceutical Gets CDSCO Panel Nod To Study Anti-rheumatoid drug Iguratimod
Indian Pharma Market Posts 9% Surge in November Even as Volumes Stay Flat: PharmaTracIndian Pharma Market Grows 7.5% in Feb 2025, But Respiratory Segment Declines by 4.6%
Pill form of Wegovy gets USFDA approval for weight lossCagriSema demonstrates superior weight loss in adults with obesity, type 2 diabetes in REDEFINE 2...
X